Economy

Needham & Company LLC Reaffirms Buy Rating for Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

(NASDAQ:NBIX) to release earnings on November, 1. Its up 6.51% from 8.57 million shares previously.

Neurocrine Biosciences (NASDAQ:NBIX) last issued its earnings results on Thursday, August 3rd. The lowest price the stock reached in the last trading day was $0.31 and compares with the $0.25 52-week low. The stock had a trading volume of 897,284 shares.

Analysts expect ImmunoGen, Inc.

As of the last earnings report the EPS was $-2.52 and is expected to be $-2.45 for the current year with 88,221,000 shares presently outstanding. Many traders will use a combination of moving averages with different time frames to help review stock trend direction.

Neurocrine Biosciences, Inc is engaged in discovering and developing pharmaceuticals, in diseases with unmet medical needs, through its research and development (R&D) platform, focused on neurological and endocrine based diseases and disorders. The stock's market capitalization is $5.19 billion. The Business's late-stage clinical programs are elagolix, which is a gonadotropin-releasing hormone (GnRH) antagonist in Phase III development for endometriosis and uterine fibroids that is partnered with AbbVie Inc.; INGREZZA (valbenazine), which is a vesicular monoamine transporter 2 (VMAT2) inhibitor, for the treatment of movement disorders, and opicapone, which is a selective catechol-O-methyltransferase (COMT) inhibitor. It now has negative earnings. Its product pipeline also includes NBI-640756 and NBI-74788.

Investors sentiment increased to 1.25 in 2017 Q2. Its up 0.22, from 1.03 in 2017Q1. Vanguard Group Inc. increased its stake in shares of Neurocrine Biosciences by 2.8% in the 2nd quarter. Jgp Global Gestao De Recursos Ltda holds 0.36% or 5,890 shares. First Mercantile Trust Co. boosted its holdings in Neurocrine Biosciences by 22.2% in the first quarter. (NASDAQ:NBIX) has a beta of 0.41. Grt Ltd has 8,169 shares for 0.22% of their portfolio. Proshare Limited Liability Corp reported 47,053 shares.

According to Zacks brokerage recommendations, Neurocrine Biosciences, Inc. Neurocrine Biosciences earned a coverage optimism score of 0.20 on Accern's scale. (NASDAQ:NBIX)'s Buy count is 1 and Strong Buy is 10 while the number of analysts recommending Sell and Strong Sell are 0 and 0, respectively. Citigroup Incorporated reported 0% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) in a report published on Thursday morning. Moreover, Great West Life Assurance Can has 0% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) opened at 58.83 on Friday. (NASDAQ:NBIX). Meeder Asset Inc reported 0% stake. Next Fincl Grp has 100 shares for 0% of their portfolio. Credit Suisse Ag owns 0.01% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 120,500 shares. BidaskClub raised Neurocrine Biosciences from a "sell" rating to a "hold" rating in a research note on Wednesday, June 21st. Therefore 100% are positive. (NASDAQ:NBIX) has risen 12.51% since September 22, 2016 and is uptrending. Jefferies reinitiated Neurocrine Biosciences, Inc. The stock of Neurocrine Biosciences, Inc. Ubs Asset Americas reported 499,947 shares. The rating was maintained by Piper Jaffray with "Overweight" on Thursday, October 8. Needham has "Strong Buy" rating and $40 target. Teachers Advisors LLC now owns 78,287 shares of the company's stock valued at $3,030,000 after purchasing an additional 4,668 shares in the last quarter. The company was maintained on Monday, October 12 by Leerink Swann. Simply put, readings in the range of 80% to 100% indicate that the security is oversold while readings in the 0% to 20% range suggest it is overbought. On Tuesday, May 2 the insider Grigoriadis Dimitri E. sold $550,000. (NASDAQ:NBIX) on Tuesday, May 23. Over the last 90 days, insiders have sold 125,655 shares of company stock valued at $7,018,148. Lippoldt Darin had sold 10,000 shares worth $532,700. Gano Kyle sold 15,000 shares worth $810,000. On Wednesday, July 5 the stock rating was maintained by Oppenheimer with "Buy". J P Morgan Chase & Co set a $57.00 price objective on Neurocrine Biosciences and gave the company a buy rating in a research report on Wednesday, May 24th. The stock has "Sector Perform" rating by RBC Capital Markets on Friday, April 29. Loop Capital initiated WNS (Holdings) Limited (ADR) (NYSE:WNS) on Tuesday, January 10 with "Buy" rating. BMO Capital Markets maintained the shares of NBIX in report on Thursday, August 3 with "Buy" rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.



Like this

loading...
loading...

Latest


27 September 2017
Notable Stock Analysts Ratings Frontier Communications Corporation (FTR)
The stock of Frontier Communications Corp (NASDAQ:FTR) has "Neutral" rating given on Tuesday, September 6 by Macquarie Research. Currently, 280 million total shares are owned by the public and among those 271.5 million shares have been available to trade.

27 September 2017
Weight Loss Saves Obese Adults Nearly $30000
High BMI can also result in high medical costs for treating the complications and productivity losses, due to missed work days. Normal weight, overweight, and obese categories were determined by Body Mass Index standards.

27 September 2017
Back With Atletico, Costa Says all's Well That Ends Well
He will be eligible for selection from January 2 when the Spanish transfer window opens and Atletico's ban ends. A Chelsea statement on Thursday had said they had agreed terms with the La Liga side for the transfer of Costa.

27 September 2017
BHP Billiton plc's (BLT) "Outperform" Rating Reaffirmed at Macquarie
ValuEngine lowered BHP Billiton PLC from a "strong-buy" rating to a " buy" rating in a report on Thursday, August 24th. Oppenheimer Asset Management Inc.'s holdings in BHP Billiton PLC were worth $849,000 as of its most recent SEC filing.

27 September 2017
Justice Dept. to Argue for Allowing Discrimination of LGBTQ Workers
Justice Department lawyer Hashim Mooppan insists that Congress never intended for that law to protect gay workers against bias. Zarda died in a base jumping accident shortly after filing the suit, and he is now being represented by his estate.

27 September 2017
Total SA (FP) PT Set at €56.00 by Goldman Sachs Group, Inc
Following the completion of the sale, the director now owns 854,925 shares of the company's stock, valued at $194,743,365.75. TRADEMARK VIOLATION NOTICE: This piece of content was published by StockNewsTimes and is the property of of StockNewsTimes.

27 September 2017
Nokia 8: 5 key features of Nokia's latest Android flagship smartphone
Nokia has smartly provided capacitive keys below the display , with a centre Home button that also acts as the fingerprint sensor. The rear camera setup can shoots videos in 4K and comes with a dual LED flash and phase detection autofocus.

27 September 2017
Venezuela slams "irrational" United States travel ban, calls for talks
The Bolivarian government also lamented the inclusion of Venezuela in a unilateral list of nations that allegedly promote terrorism.

27 September 2017
Virat Kohli equals Dhoni's record of consecutive ODI wins as captain
I was thinking this was a 330-wicket. "They were our guests, so we did not charge anything from them", said Malikram. Then, India pulled things under control and picked wickets at regular intervals to peg back the visitors.

27 September 2017
Uganda ejects lawmakers opposed to president's long rule
Critics say the action underscores a crackdown in the East African country against anyone questioning a planned constitutional amendment.